PLC Systems to Present at the ROTH Conference
2008年2月14日 - 10:57PM
PRニュース・ワイアー (英語)
FRANKLIN, Mass., Feb. 14 /PRNewswire-FirstCall/ -- PLC Systems Inc.
(AMEX:PLC) today announced that it will participate in the ROTH
20th Annual OC Growth Stock Conference on February 18-21, 2008 at
the Ritz Carlton Laguna Niguel in Dana Point, CA. PLC is scheduled
to present on February 20th beginning at 3:30 pm local time.
Presenting for the company will be Mark R. Tauscher, President and
CEO. A webcast of the presentation will be available at the
company's website (http://www.plcmed.com/) or by following this
link: http://www.wsw.com/webcast/roth16/plc/. The webcast will be
archived on the company's website for 30 days following completion
of the event. About PLC Systems Inc. PLC Systems Inc. is a medical
technology company specializing in innovative technologies for the
cardiac and vascular markets. Headquartered in Franklin, Mass., PLC
pioneered the CO2 Heart Laser System, which cardiac surgeons use to
perform CO2 transmyocardial revascularization (TMR) to alleviate
symptoms of severe angina. CO2 TMR offers a treatment option for
angina patients who suffer from severe coronary artery disease. The
CO2 Heart Laser is the world's first TMR angina relief device
cleared for commercial distribution by both the U.S. Food and Drug
Administration and Japanese Ministry of Health, Labor and Welfare,
and to obtain a CE Mark for European distribution. The company has
completed a pilot clinical safety study of its RenalGuard
Therapy(TM) and RenalGuard System. In late 2007, the company
received its CE Mark Certificate for RenalGuard System. RenalGuard
Therapy is designed to reduce the toxic effects that contrast media
can have on the kidneys. This therapy is based on the theory that
creating and maintaining a high urine output is beneficial to
patients undergoing imaging procedures where contrast agents are
used. The real-time measurement and matched fluid replacement
design of the RenalGuard System is intended to ensure that a high
urine flow is maintained before, during and after these procedures.
This should allow the body to rapidly eliminate contrast, reducing
its toxic effects. The RenalGuard System, with its matched fluid
replacement capability, is intended to minimize the risk of over-
or under-hydration. Additional company information can be found at
http://www.plcmed.com/. Contact: Mary T. Conway Conway
Communications 617-244-9682 DATASOURCE: PLC Systems Inc. CONTACT:
Mary T. Conway of Conway Communications for PLC Systems Inc.,
+1-617-244-9682, Web site: http://www.plcmed.com/
http://www.wsw.com/webcast/roth16/plc
http://www.roth.com/main/page.aspx?PageID=7000
Copyright
P L C Systems (AMEX:PLC)
過去 株価チャート
から 11 2024 まで 12 2024
P L C Systems (AMEX:PLC)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Plc Systems, (アメリカ証券取引所): 0 recent articles
その他のPlc Systems,ニュース記事